The issue focused on the drug's short-term use, with the press release saying:

"The short-term use of PCP is not the same as the use of PCP in a long-term or heavy use.... That's what's been called the PCP school of thought, and that's not the real issue. The real issue is the long-term use of PCP, and I think that's the real problem that we have to deal with."

The press release